Our result showed that the level of serum IL-8 and MMP-9 were lower in COPD patients treated with a combination approach than those treated with TBS alone after treatment, which was also consistent with the previous study. This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.